Keyphrases
Prostacyclin
100%
Lipid Mediators
100%
Thyroid Hormones
100%
Thyroid Hormone Receptor
100%
In Silico Modeling
100%
β-adrenoceptor Antagonists
100%
Nuclear Receptor
100%
Beraprost Sodium
66%
GW0742
66%
PGI2
44%
Vasodilation
22%
Receptor Antagonist
22%
IC50
22%
Pharmacological Methods
11%
Long-term Function
11%
Allosteric Control
11%
Docking Analysis
11%
Peroxisome Proliferator-activated Receptor
11%
Computational Chemistry
11%
Direct Method
11%
Chemistry Method
11%
Peroxisome Proliferator-activated Receptor Agonists
11%
Rat Mesenteric Artery
11%
Antagonistic Properties
11%
Wire Myograph
11%
Triiodothyronine
11%
Ligand Binding Site
11%
Cardiovascular Homeostasis
11%
In Silico Screening
11%
Short Half-life
11%
Receptor Subtypes
11%
IP Receptor
11%
Luciferase Reporter Assay
11%
Binding Profile
11%
Cell Surface
11%
Receptor-ligand Binding
11%
IP Receptor Agonist
11%
Medicine and Dentistry
Mediator
100%
In Silico
100%
Prostacyclin
100%
Thyroid Hormone
100%
Cell Nucleus Receptor
100%
Thyroid Hormone Receptor
100%
Receptor Antagonist
100%
Beraprost
66%
[4 [2 (3 Fluoro 4 Trifluoromethylphenyl) 4 Methyl 5 Thiazolylmethylthio] 2 Methylphenoxy]acetic Acid
66%
Receptor
33%
Hormone Receptor Blocking Agent
22%
IC50
22%
Vasodilatation
22%
Homeostasis
11%
Peroxisome Proliferator Activated Receptor
11%
Mesenteric Artery
11%
Binding Site
11%
Ligand Binding
11%
Cardiovascular System
11%
Luciferase Assay
11%
Peroxisome Proliferator Activated Receptor Agonist
11%
Liothyronine
11%
Cell Surface
11%
Biochemistry, Genetics and Molecular Biology
Prostacyclin
100%
Thyroid Hormone
100%
Thyroid Hormone Receptor
100%
Mediator
100%
Nuclear Receptor
100%
Lipid
100%
Receptor Antagonist
100%
Beraprost
66%
Vasodilatation
22%
IC50
22%
Ligand Binding
11%
Homeostasis
11%
Peroxisome Proliferator-Activated Receptor
11%
Allosteric Regulation
11%
Liothyronine
11%
Receptor Agonists
11%
Luciferase
11%
PPAR Agonist
11%
Binding Site
11%
Triiodothyronine
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prostacyclin
100%
Cell Nucleus Receptor
100%
Receptor Antagonist
100%
Thyroid Hormone Receptor
100%
Beta Adrenergic Receptor
100%
Thyroid Hormone
100%
[4 [2 (3 Fluoro 4 Trifluoromethylphenyl) 4 Methyl 5 Thiazolylmethylthio] 2 Methylphenoxy]acetic Acid
66%
Beraprost
66%
IC50
22%
Receptor
22%
Hormone Receptor Blocking Agent
22%
Peroxisome Proliferator Activated Receptor
11%
Luciferase
11%
Binding Site
11%
Receptor Agonist
11%
PPAR Agonist
11%
Liothyronine
11%